RADIOTHERAPY EFFECT ON COMPLETE BLOOD COUNT PARAMETER IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA
Keywords:Nasopharyngeal Carcinoma, Complete Blood Count, Radiotherapy
Nasopharyngeal carcinoma (NPC) is the most common malignant tumor of the nasopharynx. Radiotherapy is a therapy of choice for NPC that has been recognized for a long time and used in various centers of the world. However, radiotherapy is known to still have an adverse effect. It is common practice to evaluate Complete Blood Count (CBC) before, during, and after radiotherapy. However, there has been no study regarding the effect of radiotherapy on all CBC parameters. This study aims to analyze the effect of radiotherapy on CBC in NPC patients before and after radiotherapy treatment.
Material and methods:
This study was an observational study using secondary data from medical records at the radiotherapy outpatient clinic at Dr. Soetomo General Hospital Surabaya. The subject of this study was patients with NPC who underwent a full cycle of radiotherapy treatment on radiotherapy outpatient clinic in 2016. Patients with incomplete medical records and did not finish the radiotherapy treatment were excluded. A paired T-test and Wilcoxon signed-rank test were used for statistical analysis.
There were 105 patients included in this study. Mean Corpuscular Hemoglobin Concentration (MCHC), total leucocyte, lymphocyte, and thrombocyte was significantly decreased after a full cycle of radiotherapy (all p <0.05). Eosinophil, basophil, neutrophil, monocyte, Neutrophil to Lymphocyte ratio (NLR), and Platelet to Lymphocyte ratio (PLR) was significantly increased after a full cycle of radiotherapy (all p <0.05).
Radiotherapy had a significant effect on the CBC parameter in NPC patients.
 Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, et al. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chinese journal of cancer. 2012;31(4):185-96.
 Kemenkes. Pedoman Nasional Pelayanan Kedokteran Kanker Nasofaring. 2016.
 Chan J, Yom SS. Handbook of Evidence-Based Radiation Oncology 3rd Edition. Hansen EK, III MR, editors. Switzerland: Springer; 218.
 Scrase CD. Walter and Miller’s Textbook of Radiotherapy Seventh Edition. Symonds P, Deehan C, Mills JA, Meredith C, editors. England: Elsevier; 2012. 667 p.
 Li X, Chang H, Tao Y, Wang X, Gao J, Zhang W, et al. Revalidation of a prognostic score model based on complete blood count for nasopharyngeal carcinoma through a prospective study. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu. 2016;28(5):467-77.
 Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology. 2010;17(6):1471-4.
 Ye L, Oei RW, Kong F, Xu T, Shen C, Wang X, et al. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies. 2018;275(5):1309-17.
 Su Z, Mao YP, OuYang PY, Tang J, Xie FY. Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact. PloS one. 2015;10(9):e0136752.
 Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7.
 Chang H, Gao J, Xu BQ, Guo SP, Lu RB, Li G, et al. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution. Clinical oncology. 2013;25(11):639-46.
 Gao J, Zhang HY, Xia YF. Increased platelet count is an indicator of metastasis in patients with nasopharyngeal carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013;34(1):39-45.
 Liu L-T, Chen Q-Y, Tang L-Q, Guo S-S, Guo L, Mo H-Y, et al. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients. Cancer Res Treat. 2018;50(1):19-29.
 Jiang Y, Qu S, Pan X, Huang S, Zhu X. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma. Oncotarget. 2018;9(11):9992-10004.
 Yao JJ, Zhu FT, Dong J, Liang ZB, Yang LW, Chen SY, et al. Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area. BMC cancer. 2019;19(1):37.
 Lu A, Li H, Zheng Y, Tang M, Li J, Wu H, et al. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma. BioMed research international. 2017;2017:3047802.
 Takenaka Y, Kitamura T, Oya R, Ashida N, Shimizu K, Takemura K, et al. Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis. PloS one. 2017;12(7):e0181478.
 Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International journal of radiation oncology, biology, physics. 1995;31(5):1341-6.
 Mornex F, Pavy JJ, Denekamp J, Bolla M. [Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 1997;1(6):622-68.
How to Cite
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to The International Journal of Nasopharyngeal Carcinoma (IJNPC) as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from The International Journal of Nasopharyngeal Carcinoma (IJNPC).